CTXR

Citius Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Citius Pharmaceuticals Inc CTXR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 4.64% 1.58 06:48:33
Open Price Low Price High Price Close Price Prev Close
1.51
more quote information »

Recent News

Date Time Source Heading
4/20/20217:09IHNWFeaturedNightfood, Inc. (OTCQB: NGTF) in Walmart (NYSE: WMT) Coast to Coast over 1,000 Locations
4/20/20218:00IHNWFeaturedPharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial
4/20/20218:30IHNWFeaturedAmerican Green, Inc.™ (OTC:ERBB) Launches New Hemp Lip Balm on Amazon.com
4/20/20218:55IHNWFeaturedMedical Breakthrough Attained by Global WholeHealth Partners, Corp (OTC: GWHP) as a Leading Researcher, Believes a Dementia
4/20/202110:36IHNWFeaturedPURA Farmersville Hemp Brand Update; PAOG, ALKM and USMJ Partnerships; Pharmaceutical, Cryptocurrency And Equity Initiatives
4/20/20211:51IHNWFeaturedLegion Capital to Accept Bitcoin and Ethereum for Investments on GoLegion
4/20/20211:55IHNWFeaturedRelay Medical and Fio Partner with LifeLabs, Canadian Healthcare Leader, to Deploy Fionet Platform for COVID-19 Testing...
4/21/20216:00IHNWFeaturedNeoVolta's New Patent-Pending Technology Provides an Additional Power Option During Grid Outages
4/21/20216:25IHNWFeaturedEpazz, Inc. (OTC Pink: EPAZ) Cryptocurrency App Bitcoin Wallet 10,000+ Downloads
4/19/202106:04EDGARNotice of Effectiveness (effect)
4/16/202117:16EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
4/12/202116:11EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/12/202116:06EDGARProxy Statement (definitive) (def 14a)
4/02/202116:16EDGARSecurities Registration Statement (simplified Form) (s-3)
4/01/202116:31EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
3/26/202116:16EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
3/23/202109:00PRNUSCitius Pharmaceuticals to Highlight its Phase 3 Clinical..
3/12/202116:07EDGARProxy Statement - Notice of Shareholders Meeting..
3/12/202114:04EDGARSec Staff Action/letter (sec Staff)
3/12/202114:03EDGARSec Staff Action/letter (sec Staff)
3/04/202110:38PRNUSCitius Pharmaceuticals to Feature Product Candidates..
2/19/202117:07EDGARCurrent Report Filing (8-k)
2/19/202116:47PRNUSCitius Pharmaceuticals Announces Closing of $76.5 Million..
2/18/202116:08EDGARStatement of Changes in Beneficial Ownership (4)
2/18/202116:07EDGARStatement of Changes in Beneficial Ownership (4)
2/17/202105:43SEEKCitius Pharma slips 8% on capital raise
2/17/202100:28PRNUSCitius Pharmaceuticals Announces $76.5 Million Registered..
2/16/202115:01EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202109:15PRNUSCitius Pharmaceuticals Issues Shareholder Letter with..
2/11/202116:07EDGARQuarterly Report (10-q)
2/09/202116:05EDGARCurrent Report Filing (8-k)
2/08/202108:35PRNUSSmall and Microcap Company Investor Presentations Now..
2/05/202117:18EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
2/02/202108:00PRNUSCitius Pharmaceuticals to Present Update on Mino-Lok and..
2/01/202112:43EDGARSmall Company Offering and Sale of Securities Without..
1/29/202116:07EDGARSecurities Registration Statement (simplified Form) (s-3)
1/28/202108:35PRNCALive Investor Conference & Webinar: Small and Microcap..
1/27/202116:15EDGARCurrent Report Filing (8-k)
1/27/202113:00PRNUSCitius Pharmaceuticals Announces Closing of $20.0 Million..
1/25/202107:00PRNUSCitius Pharmaceuticals Announces $20.0 Million Private..
1/11/202108:17EDGARCurrent Report Filing (8-k)
1/06/202109:00PRNUSCitius Pharmaceuticals to Present Update on Proprietary..
12/21/202016:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
12/21/202016:06EDGARProxy Statement (definitive) (def 14a)
12/16/202016:06EDGARAnnual Report (10-k)
12/15/202009:40PRNUSCitius Holds Webinar Series on Conducting Mino-Lok Phase 3..
12/09/202009:40PRNUSCitius Pharmaceuticals Receives FDA Response and Guidance to..
12/08/202009:25EDGARCurrent Report Filing (8-k)
12/08/202009:15PRNUSCitius Pharmaceuticals Subsidiary NoveCite Announces Data..
12/03/202015:30PRNUSCitius Pharmaceuticals to Present Corporate Update at..
11/30/202009:23EDGARCurrent Report Filing (8-k)
11/30/202009:15PRNUSCitius Announces Results of Study that Mino-Lok Eradicates..
11/10/202009:30PRNUSCitius Pharmaceuticals to Present at Virtual Fall Investor..
11/09/202009:30PRNUSCitius Pharmaceuticals to Present at H.C. Wainwright 6th..
10/27/202009:00PRNUSCitius Pharmaceuticals Issues October 2020 Letter to..
10/26/202008:31EDGARCurrent Report Filing (8-k)
10/13/202007:30PRNUSNovellus Therapeutics Exclusively Licenses Induced..
10/09/202016:15EDGARCurrent Report Filing (8-k)
10/09/202016:10EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
CTXR
Citius Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.